EUVIMEDEUVIMED entdecken
LeserbriefSystematische Übersicht

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis

Matheus Souza iD, Marcio J M Amaral iD, Luan C V Lima iD

Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 5347-5351

DOI: 10.1111/dom.70642 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 09.03.2026. Verfasst von Matheus Souza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1 analogueantidiabetic druglivermeta‐analysisrandomised trialsystematic review

Autor:innen und Institutionen

  • Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Matheus Souza, Marcio J M Amaral, Luan C V Lima

Zitieren

APA

Souza, M., Amaral, M. J. M., & Lima, L. C. V. (2026). Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism, 28(6), 5347-5351. https://doi.org/10.1111/dom.70642

Vancouver

Souza M, Amaral MJM, Lima LCV. Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism. 2026;28(6):5347-5351. doi:10.1111/dom.70642

BibTeX
@article{Souza2026,
  author = {Souza, Matheus and Amaral, Marcio J M and Lima, Luan C V},
  title = {Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {5347--5351},
  doi = {10.1111/dom.70642}
}
Kostenlos starten →